Clinical Trial Results: Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating serum biomarkers to predict response to Angiotensin II in septic shock; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock
• Vasodilatory Shock

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: University of New Mexico | Conditions: Septic Shock, Vasodilatory Shock | Phase 4 | Status: COMPLETED | Results posted: 2026-07-02